Dachaigh › Gnìomhan › Regulatory Affairs Managers › Boston, MA
Regulatory Affairs Managers ann an Boston, MA: Tuarastalan H-1B
44 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an Boston, MA. Tuarastal bunasach meadhanach $180,300; leth meadhanach $147,494–$223,718.
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $91,083 |
| Ìre II (càileachail) | $155,765 |
| Ìre III (eòlach) | $190,325 |
| Ìre IV (gu lèir comasach) | $222,435 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| Vertex Pharmaceuticals Incorporated | 5 | $195,500 |
| argenx US, Inc. | 4 | $182,825 |
| General Hospital Corporation | 3 | $91,083 |
| AstraZeneca Pharmaceuticals LP | 3 | $257,088 |
| CRISPR Therapeutics, Inc. | 3 | $235,000 |
| OW North America LLC | 2 | $127,471 |
| Servier Bio-Innovation LLC | 2 | $260,580 |
| McKinsey & Company, Inc. United States | 2 | $370,450 |
| Rhythm Pharmaceuticals Inc. | 2 | $165,000 |
| Biogen Inc. | 1 | $89,960 |
| Pear Therapeutics, Inc. | 1 | $136,000 |
| Sonos, Inc. | 1 | $111,904 |
| eClinicalWorks LLC | 1 | $180,300 |
| Beth Israel Deaconess Medical Center, Inc. | 1 | $84,897 |
| Elektrofi, Inc. | 1 | $180,294 |
| InGenius LLC | 1 | $89,960 |
| Inozyme Pharma | 1 | $240,000 |
| Wayfair LLC | 1 | $169,251 |
| Praxis Precision Medicines, Inc. | 1 | $225,000 |
| Orsted North America Inc. | 1 | $330,000 |
| PepGen Inc. | 1 | $230,000 |
| Copenhagen Offshore Partners Inc. | 1 | $180,049 |
| Ultragenyx Pharmaceutical, Inc. | 1 | $210,891 |
| Labviva | 1 | $162,000 |
| AVEO Pharmaceuticals, Inc. | 1 | $160,000 |
| EMD Serono Research and Development Institute, Inc. | 1 | $176,000 |
| Alexion Pharmaceuticals, Inc. | 1 | $125,260 |
Tiotalan dreuchd
- Development Manager2
- Program Manager2
- Director, Chemistry Manufacturing Controls2
- Senior Manager, Regulatory Affairs2
- Sr Associate II, Drug Safety1
- Regulatory Senior Specialist1
- Program Sourcing Manager1
- Director - EHR Regulatory Compliance1
- Compliance Technical Specialist1
- Senior Director, Technical Operations1
- Education Project Manager1
- Senior Director Quality Compliance1
- IT Manager Internal Audit1
- Director of Safety/Pharmacovigilance1
- Chemistry Manufacturing Controls Associate Director1
Luchd-taic H-1B ann an Boston, MA →
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).